Delayed Opening – In-Service Training

ATTENTION: HealthWell Foundation’s hotline will open at 9:30 a.m. on Thursday, March 30, 2023, due to in-service training for our staff. We encourage you to continue to use our Patient, Pharmacy and Provider Portals during this time.  If you are contacting us about a payment or grant, please email us at and a representative will respond to your message as quickly as possible when our hotline re-opens.  We apologize for any inconvenience and look forward to serving you. The HealthWell Team

Dismiss alert

Multiple Myeloma - Medicare Access (Medicare patients only)

Treatments Covered

  • Abecma
  • Alkeran
  • Alkeran Iv
  • Aredia
  • Bicnu
  • Blenrep
  • Celestone
  • Cyclophosphamide
  • Cycophosphamide Intra Sol
  • Cytoxan
  • Darzalex
  • Darzalex Faspro
  • Denosumab
  • Dexamethasone Phosphate
  • Dexamethasone Sodium Phosphate
  • Doxil
  • Ellence
  • Empliciti
  • Etopophos
  • Farydak
  • Filgrastim
  • Filgrastim-sndz
  • Gammaplex
  • Gamunex
  • Gamunex-c
  • Granix
  • Hemady
  • Immune Globulin Intravenous
  • Intron-a
  • Ixazomib Oral
  • Kyprolis
  • Lenalidomide
  • Melphalan
  • Mozobil
  • Neupogen
  • Ninlaro
  • Nivestym
  • Octagam
  • Pamidronate Disodium
  • Pepaxto
  • Platinol
  • Pomalyst
  • Prednisone
  • Rayos
  • Reclast
  • Revlimid
  • Sarclisa
  • Tecvayli
  • Thalomid
  • Treanda
  • Velcade
  • Venclexta
  • Venetoclax
  • Vincasar Pfs
  • Xgeva
  • Xpovio
  • Zarxio
  • Zoledronic Acid
  • Zolinza
  • Zometa

Fund Definition

Assistance with the prescription drugs and biologics used in the treatment of multiple myeloma.

Grant Utilization

HealthWell estimates that patients use an average of $7,530 during their 12-month grant period for this disease area.

Consider Premium Assistance

Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • 1. You are being treated for Multiple Myeloma.

    Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • 2. You have Medicare.

    This is a Medicare Access Fund. In order to qualify for assistance through this fund, you must have Medicare. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.

  • 3. Your income falls within our guidelines.
    HealthWell assists individuals with incomes up to 400-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
  • 4. You are receiving treatment in the United States.

    If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

About Multiple Myeloma

Multiple myeloma is type of cancer that begins in plasma cells (white blood cells that produce antibodies). Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. Source: National Cancer Institute, Mayo Clinic


Additional Resources

You may also visit our Resource List to view other copayment organizations that may provide assistance.

Close menu